Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Liver cancer diagnostics industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Test Type trends
2.5 End-use trends
Chapter 3 Liver Cancer Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of liver cancer
3.2.1.2 Technological advancements in liver cancer diagnostics
3.2.1.3 Rising awareness and screening programs targeting high-risk populations
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of diagnostic tests
3.2.2.2 Risk of inaccurate of false results
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Key market trends
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Liver Cancer Diagnostics Market Size and Forecast, By Test Type (USD Million)
5.1 Key trends, by test type
5.2 Laboratory test
5.2.1 Biomarkers
5.2.2 Blood Tests
5.3 Imaging test
5.4 Biopsy
5.5 Endoscopy
5.6 Genomic test
5.7 Others
Chapter 6 Liver Cancer Diagnostics Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Diagnostic laboratories
6.4 Academic and research institutes
6.5 Others
Chapter 7 Liver Cancer Diagnostics Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Sweden
7.3.7 Poland
7.3.8 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Thailand
7.4.8 Philippines
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
7.6.5 Egypt
7.6.6 Turkey
Chapter 8 Company Profiles
8.1 AB SCIEX
8.2 Agilent Technologies Inc.
8.3 Becton, Dickinson & Company
8.4 Biocare Medical, LLC
8.5 bioMérieux SA
8.6 Bio-Rad Laboratories, Inc.
8.7 Danaher Corporation
8.8 Epigenomics Ag
8.9 F. Hoffmann-La Roche Ltd.
8.10 General Electric Company
8.11 Hoffmann La-Roche Ltd.
8.12 Hologic, Inc.
8.13 Johnson & Johnson
8.14 Koninklijke Philips N.V.
8.15 Qiagen N.V.
8.16 Seimens Healthineers
8.17 Sysmex Corporation
